These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9824903)

  • 1. Present status of coronary stenting: hopes and hypes.
    Fleisch M; Meier B
    Indian Heart J; 1998 Oct; 50 Suppl 1():14-7. PubMed ID: 9824903
    [No Abstract]   [Full Text] [Related]  

  • 2. Coronary angioplasty and new devices in patients with prior coronary artery bypass graft surgery.
    Ribeiro PA
    Rev Port Cardiol; 1999 Feb; 18 Suppl 1():I105-11. PubMed ID: 10191682
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulatory perspective on embolic protection device approval for saphenous vein graft stenting with a single-arm trial using risk-adjusted prediction model.
    Fiorentino RP; Zuckerman B; Uchida T
    Circulation; 2008 Feb; 117(6):714-6. PubMed ID: 18268158
    [No Abstract]   [Full Text] [Related]  

  • 4. Intragraft nicardipine prophylaxis to prevent no-reflow in triple-vessel saphenous vein graft intervention.
    Fischell T; Haller S; Ashraf K
    J Invasive Cardiol; 2005 Jun; 17(6):334-7. PubMed ID: 16003012
    [No Abstract]   [Full Text] [Related]  

  • 5. Current status of plain old balloon angioplasty.
    Deshpande NV; Serruys PW
    Indian Heart J; 1998 Oct; 50 Suppl 1():5-13. PubMed ID: 9824902
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of angioscopy on coronary interventions.
    White CJ; Ramee SR; Collins TJ; Jenkins JS
    Indian Heart J; 1998 Oct; 50 Suppl 1():89-98. PubMed ID: 9824913
    [No Abstract]   [Full Text] [Related]  

  • 7. Beyond embolic protection for saphenous vein graft disease.
    Satler LF
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):641-2. PubMed ID: 18949778
    [No Abstract]   [Full Text] [Related]  

  • 8. Percutaneous treatment of saphenous vein bypass graft obstructions: a continuing obstinate problem.
    de Feyter PJ
    Circulation; 2003 May; 107(18):2284-6. PubMed ID: 12742967
    [No Abstract]   [Full Text] [Related]  

  • 9. PTCA of degenerated vein grafts: experience of two periods (1992-93 and 1996-97) in 780 patients.
    Reifart N; Störger H; Schwarz F; Rabe A
    Indian Heart J; 1998 Oct; 50 Suppl 1():62-6. PubMed ID: 9824909
    [No Abstract]   [Full Text] [Related]  

  • 10. Should bare metal or drug-eluting stents be used during PCI of saphenous vein graft lesions: waiting for Godot?
    Brilakis ES; Berger PB
    Catheter Cardiovasc Interv; 2008 Nov; 72(6):815-8. PubMed ID: 19006238
    [No Abstract]   [Full Text] [Related]  

  • 11. Percutaneous intervention in saphenous vein bypass graft disease: case against the use of drug-eluting stents.
    Bansal D; Sachdeva R; Mehta JL
    J Am Coll Cardiol; 2008 Mar; 51(9):970-1; author reply 971-2. PubMed ID: 18308169
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of stents in the current era: long-term antiplatelet therapy and late-stent thrombosis.
    Buxton B
    ANZ J Surg; 2008; 78(1-2):2-5. PubMed ID: 18199197
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimal therapy for degenerated saphenous vein graft disease.
    Kramer B
    J Invasive Cardiol; 1995; 7 Suppl D():14D-20D. PubMed ID: 10155126
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic total occlusion treatment in post-CABG patients: saphenous vein graft versus native vessel recanalization-long-term follow-up in the drug-eluting stent era.
    Meliga E; García-García HM; Kukreja N; Daemen J; Tanimoto S; Ramcharitar S; van Mieghem CA; Sianos G; van der Ent M; van der Giessen WJ; de Feyter P; van Domburg R; Serruys PW
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):21-5. PubMed ID: 17584913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients.
    Coolong A; Baim DS; Kuntz RE; O'Malley AJ; Marulkar S; Cutlip DE; Popma JJ; Mauri L
    Circulation; 2008 Feb; 117(6):790-7. PubMed ID: 18212287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yes reflow.
    Heldman AW; Brinker JA
    Catheter Cardiovasc Interv; 1999 Aug; 47(4):404-5. PubMed ID: 10470467
    [No Abstract]   [Full Text] [Related]  

  • 17. Eosinophilic tissue response several weeks after sirolimus-eluting Cypher stent implantation within a bare metal stent in a coronary saphenous vein graft.
    Rittersma SZ; van der Wal AC; de Winter RJ
    Catheter Cardiovasc Interv; 2006 Jan; 67(1):38-40. PubMed ID: 16273582
    [No Abstract]   [Full Text] [Related]  

  • 18. Retrograde embolization during saphenous vein graft angioplasty.
    Gao W; Koh TH
    Catheter Cardiovasc Interv; 1999 Feb; 46(2):205-9. PubMed ID: 10348546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Snare extraction of a fractured coronary stent in a saphenous vein graft.
    Steinberg DH; Satler LF; Pichard AD
    Catheter Cardiovasc Interv; 2007 Aug; 70(2):241-3. PubMed ID: 17377995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting stent in saphenous vein graft lesions.
    Kornowski R
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):894-5. PubMed ID: 18498140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.